Scientists at UCSF have developed a groundbreaking method to enhance protein functionality by selectively introducing highly reactive amino acids, dehydroalanine (Dha) and dehydrobutyrine (Dhb), directly into proteins. This innovative strategy, called Genetically Encoded Chemical Conversion (GECCO), uses proximity-enabled reactivity to convert natural amino acids into reactive residues within living cells, bypassing the need for chemical treatments. GECCO has demonstrated proof-of-concept success in laboratory settings with applications in protein engineering, glycoprotein synthesis, and biochemistry research.
Proof-of-concept
| Country | Type | Number | Dated | Case |
| European Patent Office | Published Application | 2019-164 | ||
| Patent Cooperation Treaty | Reference for National Filings | WO2020/206341 | 10/08/2020 | 2019-164 |
Additional Patent Pending